APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. (Q53201479)

12 May 2018

title

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. (English)

1 reference

12 May 2018

1 reference

4

DeKosky ST

1 reference

12 May 2018

author name string

Kamboh MI

series ordinal

1

1 reference

12 May 2018

Sanghera DK

series ordinal

2

1 reference

12 May 2018

Ferrell RE

series ordinal

3

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 August 1995

1 reference

12 May 2018

published in

Nature Genetics

1 reference

12 May 2018

volume

10

1 reference

12 May 2018

page(s)

486-488

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1038/ng0895-486

exact match

0 references

cites work

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

Proteinase inhibitor alpha 1-antichymotrypsin has different expression in various forms of neuronal ceroid lipofuscinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Distribution of the Protease Inhibitor α1-Antichymotrypsin in Cerebral and Systemic Amyloid

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

?1-Antichymotrypsin Binding to Alzheimer A? Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Differential expression of alpha 1-antichymotrypsin in the aged human brain.

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

The molecular basis of alpha 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Unity in function in the absence of consensus in sequence: role of leader peptides in export

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Characterization of the serpin, alpha 1-antichymotrypsin, in normal human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study

1 reference

https://api.crossref.org/works/10.1038%2FNG0895-486

7 January 2021

Identifiers

DOI

10.1038/NG0895-486

1 reference

12 May 2018

Dimensions Publication ID

1009662325

0 references

Fatcat ID

release_wekvj6tmqjgxze22lvzhxvaxoe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wekvj6tmqjgxze22lvzhxvaxoe

24 November 2022

mapped directly with Wikidata item

PubMed ID

7670501

1 reference

12 May 2018